Cargando…
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves
COVID-19 affects the respiratory parenchyma and may potentially contribute to the tendency of myasthenia gravis (MG) patients to develop respiratory failure. It is, therefore, important to study the safety of vaccines against SARS-CoV-2 and to assess the risk of COVID-19 in MG patients. The safety o...
Autores principales: | Doron, Alon, Piura, Yoav, Vigiser, Ifat, Kolb, Hadar, Regev, Keren, Nesher, Nahum, Karni, Arnon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361942/ https://www.ncbi.nlm.nih.gov/pubmed/35907046 http://dx.doi.org/10.1007/s00415-022-11303-8 |
Ejemplares similares
-
Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study
por: Karni, Arnon, et al.
Publicado: (2022) -
JCV seroconversion rate during the SARS COVID-19 pandemic
por: Vigiser, I., et al.
Publicado: (2022) -
Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation
por: Golan, Maya, et al.
Publicado: (2021) -
Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis
por: Lotan, Itay, et al.
Publicado: (2022) -
Characterization of patients with ocular myasthenia gravis — A case series
por: Karni, Arnon, et al.
Publicado: (2016)